Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination to enhance influenza vaccine response in elderly
2019-002781-12Phase 3Completed
- Sponsor
- University of Southern Denmark
- Start
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bcg vaccine in influenza (2 arms), sponsored by University of Southern Denmark. Primary endpoint: Change in influenza antibody levels. Started Jun 2021; status: completed.
02
Drugs
bcg vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2019-002781-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002781-12.